Listed by the USPTO as VOLKOV, ALEXANDER ALEXANDROVIC
Tech Center 1700 • Art Units: 1612 1677 1678 1682 1758
This examiner grants 30% of resolved cases
VOLKOV, ALEXANDER ALEXANDROVIC works in Tech Center 1700 and Art Unit 1612. The profile reflects 95 resolved cases, a 29.5% allowance rate, and a median of 1481 days to allowance. Interviews show a 21.5% lift. The record therefore points to a demanding prosecution environment in which both substantive claim preparation and case management matter.
The listed companies are Hoffmann-La Roche Inc., Fujifilm Corporation, and Uif (university Industry Foundation), Yonsei University. The leading firms are BIRCH STEWART KOLASCH & BIRCH, LLP, BROWN RUDNICK LLP, and CHRISTENSEN O'CONNOR JOHNSON KINDNESS PLLC. Given the limited case volume, counsel should use these signals alongside the specific technology and rejection history.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18451352 | METHOD FOR RESOLVING COMPLEX, MULTISTEP ANTIBODY INTERACTIONS | Final Rejection | Hoffmann-La Roche Inc. |
| 18452029 | IMMUNOCHROMATOGRAPHIC ASSAY APPARATUS | Final Rejection | FUJIFILM Corporation |
| 18700442 | OLFACTORY RECEPTOR GENE FOR DIAGNOSING SKIN AGING AND USE THEREOF | Non-Final OA | UIF (University Industry Foundation), Yonsei University |
| 16962246 | PERIODONTAL DISEASE DIAGNOSTIC METHODS, USES AND KITS | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 17612575 | COMPUTATIONAL SENSING WITH A MULTIPLEXED FLOW ASSAYS FOR HIGH-SENSITIVITY ANALYTE QUANTIFICATION | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18573224 | METHODS AND MATERIALS FOR TREATING CANCER | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18556237 | HIGH-SENSITIVITY NANOPLASMONIC BIOSENSOR FOR DETECTING AUTOPHAGY MARKERS, MANUFACTURING METHOD THEREFOR, AND AUTOPHAGY MARKER DETECTION METHOD USING SAME | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18017563 | DUAL BARCODE INDEXES FOR MULTIPLEX SEQUENCING OF ASSAY SAMPLES SCREENED WITH MULTIPLEX INSOLUTION PROTEIN ARRAY | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 19091939 | PROTEIN PURIFICATION WITH PROTEIN L | Non-Final OA | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 18280426 | Cardiovascular Disease | Final Rejection | Sanofi |
| 18717294 | COMPOSITIONS AND METHODS FOR PREVENTION OR REDUCTION OF CARPA | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18566750 | STOOL SPECIMEN TEST METHOD AND IMMUNOCHROMATOGRAPHIC TEST PIECE THEREFOR | Non-Final OA | Denka Company Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy29.5% of resolved applications examined by Alexander Alexandrovic Volkov were allowed (95 resolved cases), compared with 40.7% across Art Unit 1612 over the last five years.
This examiner's interview lift is +21.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Alexander Alexandrovic Volkov took 1,481 days on average from filing to allowance.
Alexander Alexandrovic Volkov examines applications in Art Unit 1612 in Tech Center 1700 (Chemistry & Materials).
